Relationship between frailty and methotrexate discontinuation due to adverse events in rheumatoid arthritis patients.
Sobue Y, Suzuki M, Ohashi Y, Koshima H, Okui N, Funahashi K, Ishikawa H, Inoue H, Asai S, Terabe K, Kishimoto K, Kihira D, Maeda M, Sato R, Imagama S.
Sobue Y, et al. Among authors: ohashi y.
Clin Rheumatol. 2023 Aug;42(8):2069-2077. doi: 10.1007/s10067-023-06639-z. Epub 2023 May 22.
Clin Rheumatol. 2023.
PMID: 37211570